Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

Kurppa, Kari J., Liu, Yao, To, Ciric, Zhang, Tinghu, Fan, Mengyang, Vajdi, Amir, Knelson, Erik H., Xie, Yingtian +36 more·2020·Cancer Cell

DOI 10.1016/j.ccell.2019.12.006

Cited by (477)

Items 401–477 of 477

CDKN1B (p27 kip1 ) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors
E. Philip Horwitz, Taronish D. Dubash, Annamária Szabolcs, Ben S. Wittner, Johannes Kreuzer, Robert Tyler Morris, Aditya Bardia, Brian Chirn, Devon F. Wiley, Dante Che et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Chemotherapy-treated breast cancer cells activate the Wnt signaling pathway to enter a diapause-DTP state
Youssef El Laithy, Willy Antoni Abreu de Oliveira, A. Pabba, Alessandra Qualizza, F. Richard, Paraskevi Athanasouli, C. Luci, Wout De Wispelaere, Larissa Mourão, Siân Hamer et al. · 2024 · bioRxiv
Tumor Cell Spatial Organization Directs EGFR/RAS/RAF Pathway Primary Therapy Resistance through YAP Signaling
Rachel M. Nakagawa, Andrew R. Beardsley, Sophia Durney, Mary-Kate Hayward, Vishvak Subramanyam, Nathaniel P. Meyer, Harrison Wismer, Hani Goodarzi, Valerie Marie Weaver, Daniel Van de Mark et al. · 2025 · eLife
YAP/TAZ create a physical niche for the maintenance of adult neural stem cell quiescence
Laura Blasco-Chamarro, Pau García-Bolufer, Pere Duart-Abadía, Antonio Jordán‐Pla, Ma Salomé Sirerol-Piquer, Pau Carrillo-Barberà, Chiara Sgattoni, Isabel Mateos-White, Cristina Gil, José Manuel Morante‐Redolat et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Recurrent Escape from Osimertinib-Induced Senescence Promotes Genomic Instability Associated with Therapeutic Resistance
Nazia Jamil, Qualia Hooker, Nadjet Cornejal, H. Dean Hosgood, Hayley M. McDaid · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Incomplete ablation of colon cancer cells may induce activation of dormant cells: Evidence from bioinformatics analysis
Yuping Sun, Taiyang Zuo, Wenli Lin, Jie Liu, Wei Lv, Changling Liu · 2020 · Journal of Cancer Research and Therapeutics
SLUG is Enhanced by Chemotherapeutics and Functions to Promote Invasion and Metastasis by Directly Targeting MMP3 in Cervical Cancer
Senwei Jiang, Lan Zhang, Shuting Huang, Yun Zhou, Yanling Feng, Linjing Yuan, Yinan Jiang, Xiaojing Zheng, Jing Xu, Rongzhen Luo et al. · 2020 · Research Square
MiR-323a-3p Inhibits Tumor Growth and Gefitinib Resistance Acquisition by Targeting EGFR/ErbB3 in Colorectal Cancer
Yuanzhou Zhang, Shunshun Liang, Bowen Xiao, Jingying Hu, Yechun Pang, Yuling Liu, Juan Yang, Junpin Ao, Lin Wei, Xiaoying Luo · 2021 · Research Square
Differential Expression Analysis of RNA-Seq Data and Co-expression Networks
Sana Javed · 2021 · Computational biology
Improving cancer therapy through unconventional strategies
João M. Fernandes Neto · 2021
b.婦人科がんにおける分子標的療法(4.腫瘍)
徹杉山, 文洋村上, 敏治嘉村 · 2002 · 日本産科婦人科學會雜誌
Therapy-Induced Dormancy and Residual Disease
Ashley V. DiMarco, Nina Marie G. Garcia, James V. Alvarez · 2022 · Springer eBooks
Role of epithelial to mesenchymal transition in the resistant mechanism of EGFR-TKIs
Yuta Adachi, Hiromichi Ebi · 2023 · Elsevier eBooks
The nature of cancer
Min Yan, Quentin Liu · 2023 · Frontiers of Medicine
Data from EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody–Drug Conjugate HER3–DXd
Heidi M. Haikala, Timothy Lopez, Jens Köhler, Pınar Ö. Eser, Man Xu, Qing Zeng, Tyler J. Teceno, Kenneth H. Ngo, Yutong Zhao, Elena Vladimirovna Ivanova et al. · 2023
Data from Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer
Yukie Kashima, Daisuke Shibahara, Ayako Suzuki, Kyoko Muto, Ikei S. Kobayashi, David O. Plotnick, Hibiki Udagawa, Hiroki Izumi, Yuji Shibata, Kosuke Tanaka et al. · 2023
Data from Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance
Magda Bahcall, Cloud Peter Paweletz, Yanan Kuang, Luke J. Taus, Taebo Sim, Nam Doo Kim, Kshiti H. Dholakia, Christie J. Lau, Prafulla C. Gokhale, Pratik R. Chopade et al. · 2023
Transcriptional landscape of DTP-DTEP transition reveals DUSP6 as a driver of HER2 inhibitor tolerance via Neuregulin/HER3 axis
Majid Momeny, Mari Tienhaara, Deepankar Chakroborty, Mukund Sharma, Roosa Varjus, Joni Merisaari, Artur Padzik, Andreas Vogt, Ilkka Paatero, Kari J. Kurppa et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
The human antigen R as an actionable super-hub within the network of cancer cell persistency and plasticity
Rastine Merat · 2023 · Translational Oncology
WITHDRAWN: LINC01770 stabilizes TEAD1 expression to mediates nasopharyngeal cancer radiation resistance rendering tumor cells vulnerable to ferroptosis
Qingqing Xu, Xin Wen, Chenglong Huang, Zai-shan Lin, Zhen Xu, Ci-ming Sun, Li Li, Sui-xian Zhang, Shuanghong Song, Jia-Hao Lou et al. · 2023 · Research Square
WITHDRAWN: LINC01770 stabilizes TEAD1 expression to mediates nasopharyngeal cancer radiation resistance rendering tumor cells vulnerable to ferroptosis
2024 · Research Square
TAG Synthesis and Oxidation Activated by YAP/TEAD Confers ROS Resistance in Cancer Stem Cells
Jiun-Han Lin, Tien-Wei Hsu, Wei‐Chung Cheng, Chen‐Chi Liu, Anna Fen–Yau Li, Mien‐Chie Hung, Han‐Shui Hsu, Shih‐Chieh Hung · 2024 · Research Square
Analysis of YAP1 Gene as a Potential Immune-Related Biomarker and Its Relationship with the TAZ Expression
Shan He, Rushuang Xu, Qing Luo, Guanbin Song · 2024 · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany
Personalized Molecular Therapies for Advanced Non-Small Cell Lung Cancer: Overcoming Heterogeneity to Optimize Treatment Response and Clinical Outcomes
Zuan-Fu Lim · 2024
Tumor Cell Spatial Organization Directs EGFR/RAS/RAF Pathway Primary Therapy Resistance through YAP Signaling
Rachel Nakagawa, Andrew Beardsley, Sophia Durney, Mary-Kate Hayward, Vishvak Subramanyam, Nathaniel P. Meyer, Harrison Wismer, H. Goodarzi, V. Weaver, Daniel Van de Mark et al. · 2024 · bioRxiv
Towards the design of ligands of the internal pocket TEADs C-terminal domain
Florine Toulotte, Mathilde Coevoet, Maxime Liberelle, Fabrice Bailly, Benjamin Zagiel, Muriel Gelin, Frédéric Allemand, Patrick Fourquet, Patricia Melnyk, Jean‐François Guichou et al. · 2024 · European Journal of Medicinal Chemistry
Enhanced AkaLuc Bioluminescence Imaging for Longitudinal Intravital Monitoring of Minimal Residual Disease in a Murine Model of Triple-negative Breast Cancer
Silvia Steinbauer, James Cowles, MohammadA Sabbaghi, Marle Poppelaars, Azaz Hussain, Marina Wagesreither, Daniela Laimer-Gruber, József Tóvári, Gergely Szakács, Agnes Csiszar · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
PLK1 Downregulation Attenuates ET-1-Induced Cardiomyocyte Hypertrophy by Suppressing the ERK1/2 Pathway
Jie Ding, Anqi Yang, Liping Zhou, Fulei Zhang, Huixing Zhou, Yuemei Zhang, Yan Wang, Yi Liu, Dandan Liang, Yahan Wu et al. · 2025 · Journal of Cardiovascular Translational Research
Slow‐Release Prostacyclin Agonist‐Immersed Sheet Implantation Suppresses Liver Fibrosis via Hippo Signaling Pathway Activation
Wataru Fujii, Yoshito Tomimaru, Shogo Kobayashi, Kosuke Torigata, Kouichi Hasegawa, Akima Harada, Kazuki Sasaki, Shinichiro Hasegawa, Daisaku Yamada, Hirofumi Akita et al. · 2025 · Hepatology Research
Cellular dynamics in the dormant embryo
Rui Chen, Ivan Bedzhov · 2025 · BIOspektrum
MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines
Hyun-Min Ryu, Deokhoon Kim, Jun Yong Choi, Shinkyo Yoon, Ho‐Su Lee, Ji Eun Park, Eunjin Lee, Yunkyung Sung, Chang Hoon Lee, Eun-Young Lee et al. · 2025 · Cellular and Molecular Life Sciences
Targeting Posttranslational Modifications in the Tumor Stromal Microenvironment for Antitumor Therapy
Huiguo Qing, Xiangyan Jiang, Yong Ma, Zongrui Xing, Yuxia Wu, Keshen Wang, Hongtai Cao, Zuoyi Jiao, Zeyuan Yu · 2025 · Molecular Carcinogenesis
CDK4/6 inhibition induces a DNA damage-independent senescence-associated secretory phenotype driven by delayed activation of NF-κB
Joanna Lan-Hing Yeung, Justin Rendleman, Lauren Anderson Westcott, Arnold Ou, Matthew Pressler, Nicole Pagane, Irene Duba, Ria Hosuru, Bat‐Ider Tumenbayar, Viviana I. Risca · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Targeting transcription factors in cancers
Lu Hu, Jianan Zhang, Xu Wu · 2025 · Elsevier eBooks
YAP/TEAD4-regulated placental alkaline phosphatases ALPP and ALPPL2 are immunosuppressive ectonucleotidases modulated by MAPK inhibitors
J. Martin, Bruce K. Huang, T. Ehrenberger, A. R. Hasan, Michelle Dow, W. Khoo, R. Pacaud, Essam Metwally, Katherine Porth, Gukhan Kim et al. · 2025 · bioRxiv
Combined MEK and YAP inhibition in a mouse model of neuroblastoma: A promising approach for minimal residual disease
Ryota Tsuji, Tomoko Tanaka, Shigehisa Fumino, Kiyokazu Kim, Shohei Takayama, Masafumi Iguchi, Masakazu Takemoto, Tatsuro Tajiri, Shigeru Ono · 2025 · Journal of Pediatric Surgery
Cell shape dynamics during mouse peri-implantation development and embryo dormancy
Deepthi Chandramohan, Fei Chen, Rui Chen, Ivan Bedzhov · 2025 · Current topics in developmental biology/Current Topics in Developmental Biology
Pause and play: insights into mammalian embryonic diapause
Rui Chen, Ivan Bedzhov · 2025 · Development
Lysine methylation-mediated SMYD2 degradation by casticin sensitizes non-small-cell lung cancer cells to osimertinib therapy
Kailing Pan, Bo Xu, Yang Lie Guang Lou, Jianbo Xue, Xuehang Jin, Michaël Dang, Si-Yuan Pan, Zan Huang, Xianguo Chen · 2025 · Biochemical Pharmacology
YAP/TEAD-activated TAG synthesis and peroxidation in lipid droplets confer ROS resistance in cancer stem cells
Jiun-Han Lin, Tien-Wei Hsu, Wei‐Chung Cheng, Chen‐Chi Liu, Anna Fen–Yau Li, Mien‐Chie Hung, Han‐Shui Hsu, Shih‐Chieh Hung · 2025 · Redox Biology
Additional file 2 of Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase
Ruihua Liu, Shang Su, Xing, Jing, Ke Liu, Zhao, Yawei, Mary M. Stangis, Diego Jacho, Eda D. Yildirim-Ayan, Cara M. Gatto-Weis, Bin Chen et al. · 2024 · Figshare
Additional file 1 of Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors
Garcia-Rendueles, Maria E. R., Gnana Prakasam Krishnamoorthy, Mahesh Saqcena, Adrián Acuña-Ruíz, Giovanna Revilla, de Stanchina, Elisa, Jeffrey A. Knauf, Rona Lester, Bin Xu, Ghossein, Ronald A. et al. · 2024 · Figshare
YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer
Meija Honkanen, Jonas Baumgarten, Nikol Dibus, Jenna H. Rannikko, Miloš Gojković, Paloma Cejas, Yingtian Xie, Zsuzsanna Ortutay, Johannes A. M. Merilahti, Mari Tienhaara et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Targeting Cellular Senescence in Prostate Cancer: Molecular Landscape and Therapeutic Avenues
Haneen Hossam, Bandar Alattaibi · 2026 · annals of urologic oncology
Neveskin from Ferula samarcandica exerts anti-gastric cancer effects via the Hippo-YAP signaling pathway
Mayire Nueraihemaiti, Khamidulla Kamoldinov, Xueying Lu, Chao Niu, Dan Tang, Jiangyu Zhao, Haji Akber Aisa · 2026 · Phytomedicine
Discovery of a potent and orally bioavailable reversible TEAD inhibitor (R)-3-(5-(1-methyl-3-((4-(trifluoromethyl)phenyl)amino)-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl)-3-vinylpyrrolidin-2-one
Jian Cao, Xiaojun Han, Kimberlee M. Fischer, Nicolas Villanueva, Christian C. Lee, Quyen-Quyen Do, Jiali Li, Wen‐An Pan, Summer Sund, Gijsbertus J. Pronk et al. · 2026 · Results in Chemistry
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion
Claudia Gentile, William W. Feng, Sean M. Lenahan, Alexander Wang Ying, Daren C. Card, Florence T.H. Wu, Nhu‐An Pham, Nikolina Radulovich, Pinjiang Mary Cao, K. Hueniken et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
A Fragment Screen Identifies Acrylamide Covalent Inhibitors of the TEAD•YAP Protein-Protein Interaction
Khuchtumur Bum‐Erdene, Mona K. Ghozayel, Mark J. Zhang, Giovanni González-Gutiérrez, Samy O. Meroueh · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Compréhension des étapes précoces de la résistance adaptative aux inhibiteurs de tyrosine kinase de l'EGFR dans les cancers bronchiques
Sarah Figarol · 2020 · theses.fr (ABES)
Une nouvelle stratégie thérapeutique pour prolonger la réponse du cancer bronchique aux inhibiteurs d’EGFR en prévenant l’émergence des cellules résistantes
Lisa Brunet · 2021 · theses.fr (ABES)
Unraveling escape and metastasis mechanisms in triple negative breast cancer following chemotherapy treatment
Amina Naït Eldjoudi · 2023 · theses.fr (ABES)
Elevated Expression of MALAT1 Contributes to the Survival of Drug-Tolerant Persister Cells Following Targeted Therapy in Lung Adenocarcinoma
William J. H. Davis, M Thompson, Safia M Farry, Cushla McKinney, Grégory Gimenez, Mark E. Hatley, Rajiv Kumar, Euan James Rodger, Aniruddha Chatterjee, Sarah D. Diermeier et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Engineered matrices reveal sulfation-mediated stress adaptation and drug-specific modulation of chemotherapeutic response
Sevgi Sarıca, Ece Öztürk · 2026 · Biomaterials Science
EGFR ‐Targeted RNA –Exosome Nanoparticles Delivering Paclitaxel Suppress Colorectal Cancer via PRELP Upregulation
Q Li, Yong Ji, ZuoJun Zhen, YinTao He · 2026 · Journal of Biomedical Materials Research Part B Applied Biomaterials
Regulatory roles of protein palmitoylation in modulating gene regulation and protein stability
Pan Wang (198097), Aiyu Guo, Keying Li, Yifan Cui, Huimin Wang, Eryan Kong · 2026 · Trends Open
Insights Into the Molecular Mechanisms and Use of Cancer Dormancy and Reawakening
Ismail Ibrahim Al-Janabi · 2026 · Al-Rafidain Journal of Medical Sciences
A tissue-aware computational framework for confounding-controlled co-expression network analysis: Context-dependent utility in drug sensitivity modelling
Marc Ríos Cadenas, Iván Segura-Carmona, Aurelio López López, Francisco Gómez-Vela · 2026 · Computational Biology and Chemistry
Drug-tolerant persister cells in lymphoid malignancies: from mechanisms to therapeutic opportunities
Meng Li, Suping Tang, Peng Yang, Hao Zhou · 2026 · Frontiers in Oncology
Tumor cells escape from therapy-induced senescence: from molecular mechanisms to targeted intervention
Yu Han, Lie Ma, Xiangyu Ma · 2026 · Biology Direct
AXL phosphosite mapping links FAK1 and YAP1 signaling to erlotinib resistance in EGFR-mutant lung cancer
Marc Creixell, Scott D. Taylor, Jacqueline S. Gerritsen, Mingxuan Jiang, Song Yi Bae, Teresa Augustin, Michelle Loui, Carmen Boixo, Saki Minamino, Victoria Gong et al. · 2026 · Cell Reports
PARP inhibition enhances the antitumor activity of HER3-DXd in non-small cell lung cancer
Linh Lin, N. Moradi, Iris A.K. Lähdeniemi, Hanna K. Laitinen, Bassel Alsaed, Lilja Lahtinen, Timothy Lopez, Shadi Jansouz, Aine Knott, Kara M. Soroko et al. · 2026 · Cell Reports Medicine
The Crosstalk Between YAP/TAZ and Cancer Metabolism: From Mechanistic Insights to Drug Discovery
Yinhuang Gao, Minghong Chen, Songxia Lin, Min Huang, Jing Jin · 2026 · International Journal of Molecular Sciences
Mitochondrial niches of residual disease in EGFR-mutant NSCLC: immune-constrained persistence and therapeutic interception
Zhanhao Liang, Xutong Zhao, Mingru Jiang, Meizhu Zhou, Miao Cheng, Shibiao Liu, Yi Zhao · 2026 · Frontiers in Immunology
An artificial antibody-based modular platform for targeted degradation of cellular membrane proteins
Jiewen Deng, Jie Liu, Zheng Chu, Yuan Guo, Yuan-Yuan Liu, Tiange Gao, Yan Wang, Chenxi Lou, Huan Tang, Haifang Wang et al. · 2026 · Nano Today
Targeting metabolic reprogramming in persister cancer cells: Emerging insights and therapeutic opportunities
Siqi Li, Chunxiu Xiao, Jinxing Huang, Jinghong Xian, Kai Xiao · 2026 · Chinese Medical Journal
Drug resistance in cancer: Emerging mechanisms, translational barriers, and pharmacological strategies
Xiang Chen, Qinguo Huang, Ryan Li, Lu-Qi Cao, Kunxiang Gong, Ning Wang, Charles R. Ashby, Jia Gu, Zhe‐Sheng Chen · 2026 · Pharmacology & Therapeutics
Precision oncology in GI-cancers: Mechanisms of action, indications and ongoing strategies to overcome primary and secondary resistance
Laia Aceituno, Elena Valenzi, Oreste Segatto, Anna Lena Saborowski, Arndt Vogel · 2026 · Seminars in Cancer Biology
Hippo Pathway–YAP/TAZ Signaling: Molecular Mechanisms, Biological Function, Diseases, and Therapeutic Targets
Xiaodan Qu, Zhan‐you Wang · 2026 · MedComm
Persistent TOP1 cleavage complexes in drug-tolerant cells drive adaptive resistance to EGFR-targeted therapies in lung cancer
Mathéa Géraud, Rémi Gence, Anne Casanova, Estelle Clermont, Simona Salimbeni, Nesibe Özsu, Maïna Vienne, Célia Delahaye, Elodie Borrull, Amélie Lusque et al. · 2026 · Science Advances
Cellular memory after cancer therapy: persistence after drug withdrawal, maintenance across cell divisions, and responses to rechallenge
Chengyan Shi, Ruikun Jiang, Jun Yan · 2026 · Frontiers in Pharmacology
Epigenetic regulation of cancer stem cell plasticity and relapse competence in EGFR-mutant lung cancer
Xiangxiang Sun, Shengshan Xu, Qian Guo · 2026 · Frontiers in Oncology
Erasing the invisible: targeting persister cells to cure minimal residual disease
Yu Wang, Zijian Shi, Fangquan Xu, Yun Zhu, Chao Liu, Bo Wang, Ning Ji, Zhenduo Wang, Sinan Wang, Xuan Zhou et al. · 2026 · Holistic Integrative Oncology
BindingDB Entry 50014893: Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.
BindingDB · 2023 · UC San Diego
BindingDB Entry 50020114: A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities.
BindingDB · 2024 · UC San Diego
BindingDB Entry 50023109: Selective Degradation of TEADs by a PROTAC Molecule Exhibited Robust Anticancer Efficacy In Vitro and In Vivo.
BindingDB · 2026 · UC San Diego
BindingDB Entry 50004509: Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics.
BindingDB · 2026 · UC San Diego
Residual disease as a therapy-remodeled ecosystem: spatial niches, tumor persistence, and relapse in solid tumors
Nataša Prvulović Bunović, Olivera Ivanov, Saima Korać, Nikola Denda, Ivana Majkić, Nemanja Maletin · 2026 · Frontiers in Oncology